Incyte Corporation
INCY NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 28, 2026
ET
EPS Est.
2.15
EPS Actual
3.09
Revenue Est.
$1.5B
Revenue Actual
$1.67B
Next Earnings Report
Date
Oct 27, 2026 · Tue
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-3.34
Revenue Est.
$1.47B
Company Overview
Incyte Corporation (ticker INCY) is listed on NASDAQ with a market cap of about $25.91B. Its next earnings report (FY2026 Q3) is expected on Oct 27, 2026 (ET), Pre-market, with consensus EPS of -3.34. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 7, 2023 → Jul 28, 2026
Feb 7, 2023Range: -1.82 ~ 3.09Jul 28, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 28, 2026 | -- | 2.15 | Above forecast↑3.09 | $1.5B | $1.67B |
| Apr 28, 2026 | -- | 1.34 | Above forecast↑1.81 | $1.22B | $1.27B |
| Feb 10, 2026 | -- | 1.90 | 1.80 | $1.35B | $1.51B |
| Oct 28, 2025 | -- | 1.66 | Above forecast↑2.26 | $1.35B | $1.37B |
| Jul 29, 2025 | -- | 1.39 | 1.57 | $1.26B | $1.22B |
| Apr 29, 2025 | -- | 1.01 | 1.16 | $1.15B | $1.05B |
| Feb 10, 2025 | -- | 1.57 | 1.43 | $1B | $1.18B |
| Oct 29, 2024 | -- | 1.12 | 1.07 | $1.14B | $1.14B |
| Jul 30, 2024 | -- | 0.78 | Below forecast↓-1.82 | $1.03B | $1.04B |
| Apr 30, 2024 | -- | 0.84 | Below forecast↓0.64 | $921.9M | $880.9M |
| Feb 13, 2024 | -- | 1.16 | 1.06 | $1B | $1.01B |
| Oct 31, 2023 | -- | 1.09 | 1.10 | $966.9M | $919M |
| Aug 1, 2023 | -- | 0.83 | Above forecast↑0.99 | $910.3M | $954.6M |
| May 2, 2023 | -- | 0.56 | Below forecast↓0.37 | $859.2M | $808.7M |
| Feb 7, 2023 | -- | 0.58 | 0.62 | $878.3M | $926.7M |
Original Filings (SEC)
10-Q2026-07-28 ↗
8-K2026-07-28 ↗
8-K2026-07-06 ↗
8-K2026-06-22 ↗
8-K2026-06-09 ↗
8-K2026-06-08 ↗
10-Q2026-04-28 ↗
8-K2026-04-28 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
